Detalhe da pesquisa
1.
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy.
Cancer Rep (Hoboken)
; 7(3): e1954, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441358
2.
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel.
Biomark Res
; 11(1): 73, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491309